Assessment of adherence to guidelines for biochemical monitoring and ursodeoxycholic acid treatment response in a retrospective cohort of US patients with primary biliary cholangitis
In a large US PBC cohort, there were concerning levels of non-adherence to recommended biochemical monitoring. Receipt of care from a specialist was associated with higher rates of monitoring. Strategies to increase rates of biochemical testing are needed.
Authors
- Sheri Trudeau (ORCID: https://orcid.org/0000-0003-1280-0833)
- Mark A. Schmidt (ORCID: https://orcid.org/0000-0002-7440-7183)
- Christopher L. Bowlus (ORCID: https://orcid.org/0000-0002-3906-6811)
- Stuart C. Gordon (ORCID: https://orcid.org/0000-0001-8666-3849)
- Loralee B. Rupp (ORCID: https://orcid.org/0000-0002-2048-5100)
- Amandeep Sahota (ORCID: https://orcid.org/0000-0002-2270-0046)
- Yihe G. Daida (ORCID: https://orcid.org/0000-0003-1628-0476)
- Christina Melkonian
- Mei Lü (ORCID: https://orcid.org/0000-0002-3313-6428)
Institutions
- Hawaii Department of Health (US)
- Kaiser Permanente (US)
- Henry Ford Health System (US)
- Wayne State University (US)
- Kaiser Permanente Center for Health Research (US)
- University of California, Davis (US)
- Michigan State University (US)
Publication Details
- Journal
- BMJ Open Gastroenterology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjgast-2025-001899
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Intercept Pharmaceuticals